NASDAQ
Propanc Biopharma, Inc. (PPCB) has a free cash flow growth of -13.00% as of Friday, May 29, 2026. This represents a 99.34% increase compared to its 12-month average of -1967.79%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.